Suppr超能文献

乌干达与东南亚相比的恶性疟原虫kelch13突变选择:一项建模研究。

Selection of Plasmodium falciparum kelch13 mutations in Uganda in comparison with southeast Asia: a modelling study.

作者信息

Meier-Scherling Cecile P G, Watson Oliver J, Asua Victor, Ghinai Isaac, Katairo Thomas, Garg Shreeya, Conrad Melissa D, Rosenthal Philip J, Okell Lucy C, Bailey Jeffrey A

机构信息

Center for Computational Molecular Biology, Brown University, Providence, RI, USA.

Medical Research Council Centre for Global Infectious Disease Analysis, Imperial College London, London, UK.

出版信息

Lancet Microbe. 2025 May;6(5):101027. doi: 10.1016/j.lanmic.2024.101027. Epub 2025 Mar 17.

Abstract

BACKGROUND

Artemisinin partial resistance, mediated by mutations in the Plasmodium falciparum kelch13 gene (k13), rapidly spread in southeast Asia, undermining the antimalarial effectiveness of artemisinin-based combination therapies. k13 mutations have also arisen in Africa, but their rates of increase are not well characterised. We aimed to quantify the selection of k13 mutations in Africa and compare the selection with that in southeast Asia.

METHODS

In this modelling study, we investigated k13 mutation allele frequency at 16 sites in Uganda (2016-22) and five sites in southeast Asia (in Cambodia, Thailand, and Viet Nam; 2003-14). The Ugandan data were obtained from annual clinical surveillance studies and the southeast Asian data were obtained from the MalariaGEN Pf7 dataset. We investigated five validated and candidate k13 mutations: Pro441Leu, Cys469Phe, Cys469Tyr, Arg561His, and Ala675Val. We calculated annual selection coefficients using Bayesian mixed-effect linear models. We then tested whether the k13 mutation allele frequency in southeast Asia could have been forecast accurately using up to the first 5 years of available data and forecast future k13 mutation allele frequency in Uganda.

FINDINGS

We used data from 7564 samples from Uganda and 6568 samples from southeast Asia. The annual selection coefficient of evaluable k13 mutations (Pro441Leu, Cys469Phe/Tyr, Arg561His, and Ala675Val) across all sites was estimated at 0·381 (95% credible interval 0·298 to 0·472) per year, a 38% increase in relative allele frequency. Selection coefficients across Uganda were 0·494 (-0·462 to 1·410) for Pro441Leu, 0·324 (-0·629 to 1·150) for Cys469Phe, 0·383 (0·207 to 0·591) for Cys469Tyr, and 0·237 (0·087 to 0·403) for Ala675Val. In southeast Asia, the selection coefficients were 0·627 (-0·088 to 1·312) for Cys580Tyr, 0·224 (-0·903 to 1·397) for Arg539Thr, and 0·330 (-0·075 to 0·683) for all validated k13 mutations. Compared with out-of-sample data, the forecasts for southeast Asia underestimated mutation allele frequency and were of variable accuracy. Overall, forecast allele frequencies for Uganda, assuming constant selection, neared fixation (>0·95 allele frequency) within a decade (between 2031 and 2033) for combined k13 mutations.

INTERPRETATION

k13 mutation selection in Uganda was similar to that observed in southeast Asia, suggesting that frequencies of k13 mutations will continue to increase quickly in Uganda. These commensurate levels of selection indicate a high potential for rapid transmission across other parts of Africa, underscoring the urgent need for treatments and policies to mitigate the spread and impact of k13 mutations.

FUNDING

US National Institutes of Health.

摘要

背景

由恶性疟原虫kelch13基因(k13)突变介导的青蒿素部分抗性在东南亚迅速传播,削弱了以青蒿素为基础的联合疗法的抗疟效果。k13突变在非洲也有出现,但其增加速率尚未得到充分描述。我们旨在量化非洲k13突变的选择情况,并与东南亚的选择情况进行比较。

方法

在这项建模研究中,我们调查了乌干达16个位点(2016 - 2022年)和东南亚5个位点(柬埔寨、泰国和越南;2003 - 2014年)的k13突变等位基因频率。乌干达的数据来自年度临床监测研究,东南亚的数据来自疟疾基因组Pf7数据集。我们研究了5个已验证的和候选的k13突变:Pro441Leu、Cys469Phe、Cys469Tyr、Arg561His和Ala675Val。我们使用贝叶斯混合效应线性模型计算年度选择系数。然后,我们测试了是否可以使用多达前5年的可用数据准确预测东南亚的k13突变等位基因频率,并预测乌干达未来的k13突变等位基因频率。

结果

我们使用了来自乌干达的7564个样本和来自东南亚的6568个样本的数据。所有位点可评估的k13突变(Pro441Leu、Cys469Phe/Tyr、Arg561His和Ala675Val)的年度选择系数估计为每年0·381(95%可信区间0·298至0·472),相对等位基因频率增加38%。乌干达各地Pro441Leu的选择系数为0·494(-0·462至1·410),Cys469Phe为0·324(-0·629至1·150),Cys469Tyr为0·383(0·207至0·591),Ala675Val为0·237(0·087至0·403)。在东南亚,Cys580Tyr的选择系数为0·627(-0·088至1·312),Arg539Thr为0·224(-0·903至1·397),所有已验证的k13突变的选择系数为0·330(-0·075至0·683)。与样本外数据相比,东南亚的预测低估了突变等位基因频率,且准确性各异。总体而言,假设选择恒定,乌干达联合k13突变的预测等位基因频率在十年内(2031年至2033年之间)接近固定(等位基因频率>0·95)。

解读

乌干达的k13突变选择与在东南亚观察到的情况相似,这表明乌干达k13突变的频率将继续快速增加。这些相当的选择水平表明在非洲其他地区有快速传播的高潜力,强调了迫切需要采取治疗方法和政策来减轻k13突变的传播和影响。

资助

美国国立卫生研究院。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbb6/12128186/b1d832a0ba19/nihms-2081035-f0001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验